Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Dacinostat impairs short-term engraftment potential of leukemic stem cells
RPE cells differentiate into a functional monolayer
Solubility: DMSO: 76 mg/mL(199
Molecular Weight: 503
Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains
MS023 - PRMT Inhibitor. CAS# 1831110-54-3 0331 Dacinostat impairs short-term engraftment potentialMS023, CAS No. 1831110 54 3, is a potent, selective and cell permeable type I PRMT inhibitor (catalyzes mono and asymmetric dimethylation of arginine residues) with IC50 of 30 nM, 119 nM, 83 nM, 4 nM and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6 and PRMT8, respectively. It is completely inactive against type II and type III PRMTs, protein lysine methyltransferases and DNA methyltransferases. A crystal structure of PRMT6 in complex with MS023 revealed that
US$ 5735.00
US$ 2575.00
US$ 3280.00
US$ 480.00
US$ 1015.00
US$ 103.00
US$ 300.00
US$ 1675.00
US$ 1570.00